Cardiac hypertrophy and insulin therapy in a pre-term newborn: is there a relationship?
Abstract Background Hypertrophic cardiomyopathy (HCM) in newborns is a rare condition with heterogeneous etiologies. While the relationship between hyperinsulinism and cardiac hypertrophy (CH) is known, hyperinsulinism has not been reported as cause of HCM. Case presentation We report the case of ca...
Saved in:
Main Authors: | Guglielmo Salvatori (Author), Giulia Brindisi (Author), Mario Colantonio (Author), Anna Maria Zicari (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of cardiac hypertrophy in the setting of sudden cardiac death
by: Kristopher S. Cunningham, et al.
Published: (2019) -
Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis
by: Yan Chen, et al.
Published: (2022) -
Circular RNAs in the regulation of cardiac hypertrophy
by: Siyi Wu, et al.
Published: (2022) -
Reversing Cardiac Hypertrophy at the Source Using a Cardiac Targeting Peptide Linked to miRNA106a: Targeting Genes That Cause Cardiac Hypertrophy
by: G. Ian Gallicano, et al.
Published: (2022) -
Raf-mediated cardiac hypertrophy in adult Drosophila
by: Lin Yu, et al.
Published: (2013)